跳到正文
Cell Reports Medicine· Schwartz·收录于· 6 天前

Microbiome-antibiotic-immune interactions influence mortality in preterm infant gut microbiota-humanized gnotobiotic mice

Microbiome-antibiotic-immune interactions influence mortality in preterm infant gut microbiota-humanized gnotobiotic mice

原文摘要

出版方登记 · OpenAlex

Infants born preterm are treated with antibiotics when bacterial infection is suspected. Antibiotics disrupt the gut microbiota, leading to unfavorable immune and infectious consequences. However, the impact of specific antibiotics on gut microbial and immune responses is largely unknown. We develop a humanized gnotobiotic mouse model where we gavage preterm infant stool into germ-free dams. We treat microbiota-humanized pups with subcutaneous antibiotics with probenecid to model empiric sepsis treatment regimens. Pups humanized with microbiota including ampicillin-resistant Enterobacteriaceae die during ampicillin with probenecid treatment with increased gut permeability and systemic microbial spread. Conversely, pups with microbiota containing gelatinase-expressing Enterococcus faecalis die during meropenem with probenecid treatment with increased gut E. faecalis and systemic immune dysregulation. Gut E. faecalis, especially strains containing gelE and fsr, increase in human preterm infant gut microbiomes after meropenem. These data raise concerns about the unintended consequences of antibiotic treatment and provide a framework for understanding microbiome-antibiotic-immune interplay.

页面未能读取全文,以上为出版方登记的摘要;方法与图表见原文

来源:Cell Reports Medicine · doi.org